Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences Liquid Biopsies and Minimally-Invasive Diagnostics 2017

Allison Ballmer's Biography



Allison Ballmer, International Business Leader, Roche Molecular Systems, Inc.

Allison Ballmer is an International Business Leader at Roche Sequencing leading the Global Portfolio for Roche’s revolutionary Next Generation Sequencing platforms, delivering medically meaningful solutions for future clinical applications. Ms. Ballmer has held Business Development and Commercial leadership roles in Molecular Diagnostics with a particular emphasis in Oncology. She began her career in Cancer Diagnostics holding leadership roles in Engineering and Operations, Quality and Regulatory. Ms Ballmer serves on the Advisory Board of Techbridge Girls, a non-profit helping advance girls and underrepresented minorities in STEM. She earned her B.S. in Mechanical Engineering from Virginia Tech and Marketing certifications from Cornell University. She enjoys Career and Life Coaching and is a certified practitioner of Internal Family Systems Therapy.

Allison Ballmer Image

Considering the Role of NGS in the Clinic

Thursday, 5 October 2017 at 17:30

Add to Calendar ▼2017-10-05 17:30:002017-10-05 18:30:00Europe/LondonConsidering the Role of NGS in the ClinicLiquid Biopsies and Minimally-Invasive Diagnostics 2017 in Coronado Island, CaliforniaCoronado Island, CaliforniaSELECTBIOenquiries@selectbiosciences.com

Exploring the deployment of NGS in a clinical context: addressing the current status and considering the future trajectory.


Add to Calendar ▼2017-10-05 00:00:002017-10-06 00:00:00Europe/LondonLiquid Biopsies and Minimally-Invasive Diagnostics 2017Liquid Biopsies and Minimally-Invasive Diagnostics 2017 in Coronado Island, CaliforniaCoronado Island, CaliforniaSELECTBIOenquiries@selectbiosciences.com